Efficacy and Safety of Fecal Microbiota Transplantation in Children with Refractory Functional Abdominal Pain Disorders: An Open-Label Pilot Trial with Exploratory Microbiome Analyses
This open-label pilot trial demonstrates that fecal microbiota transplantation (FMT) combined with conventional therapy is safe and significantly more effective than conventional therapy alone in treating children with refractory functional abdominal pain disorders, while also identifying specific gut microbiota dysbiosis patterns that could serve as diagnostic and predictive biomarkers.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For many children, the stomach ache that wakes them up in the middle of the night or keeps them from school is not caused by a virus, a parasite, or a physical injury. Instead, it is a functional disorder, meaning the body's internal machinery is working in a way that causes real pain, even though a standard medical scan shows everything looks normal. These conditions, often grouped under names like irritable bowel syndrome or functional dyspepsia, are driven by a complex conversation between the brain and the gut. Recent science has revealed that this conversation is heavily influenced by the trillions of tiny bacteria living inside our intestines. When this community of microbes gets out of balance, it can send false alarm signals to the brain, creating chronic pain and digestive distress. For years, doctors have struggled to treat these cases because standard medicines often offer only temporary relief, leaving families searching for a way to reset the system.
A team of researchers at Huazhong University of Science and Technology in China decided to investigate whether they could fix this broken system by introducing a healthy community of bacteria from a donor. They focused on children who had suffered from these painful stomach issues for at least six months and had not gotten better with standard treatments. The study began by looking closely at the gut bacteria of 47 children with these chronic pain disorders and comparing them to 39 healthy children. The researchers found a stark difference: the children with pain had a gut environment that was significantly less diverse and dominated by a specific group of bacteria known to cause inflammation, while the healthy children had a more balanced and varied microbial community. This imbalance suggested that the gut was in a state of ecological collapse, where harmful bacteria had taken over and beneficial ones had disappeared.
To test if restoring this balance could stop the pain, the researchers set up a trial where the children with chronic pain received either their usual medical care or their usual care plus a fecal microbiota transplant. This procedure involves transferring stool from a carefully screened, healthy donor into the patient's gut. In this study, the transplant was delivered in two ways: either as a liquid infusion through a scope or as a capsule containing freeze-dried bacteria that the child swallowed. The goal was to see if introducing a healthy microbial ecosystem could calm the gut and stop the pain signals. The study was designed to be open, meaning the doctors and families knew which treatment was being used, and the children were assigned to groups based on what their families preferred rather than by a random lottery.
The results showed a clear and rapid improvement in the children who received the transplant. Within four weeks, nearly 70 percent of the children in the transplant group reported a significant reduction in their pain and digestive symptoms, compared to only about 14 percent of those who received standard care alone. This difference did not fade away; by the eighth week, the improvement in the transplant group remained strong, with over 80 percent of those children still feeling much better, while the improvement in the standard care group had stalled at just under 50 percent. The children who received the transplant also saw their gut bacteria change. The harmful, inflammatory bacteria dropped, and the beneficial bacteria that produce soothing compounds for the gut lining increased significantly. The overall diversity of their gut microbes grew, moving their internal ecosystem closer to that of a healthy child.
The researchers also looked at whether they could predict which children would respond best to the treatment before it even started. By analyzing the specific types of bacteria present in a child's gut, they built a computer model that could identify patterns associated with success. The model suggested that children who had a specific mix of bacteria before the transplant were much more likely to see their pain disappear. While these predictions are still in the early stages of testing, they point toward a future where doctors might be able to choose the right treatment for the right child based on their unique microbial fingerprint. The treatment was found to be safe, with the most common side effect being temporary constipation, which resolved on its own. No serious or dangerous side effects were reported during the eight-week observation period.
This study provides a strong signal that the gut bacteria play a central role in these difficult-to-treat childhood pain disorders and that resetting this ecosystem can bring lasting relief. The researchers found that children with these conditions have a gut environment that is fundamentally different from healthy children, and that introducing a healthy community of bacteria can repair that environment. While the study was small and stopped early because it was hard to find enough participants, the results were consistent and statistically significant. The findings suggest that for children who have suffered for a long time without relief, a fecal microbiota transplant combined with standard care offers a powerful new way to restore health. The work also highlights that the path to recovery is not just about stopping pain, but about rebuilding the complex, living community inside the gut that keeps the body running smoothly.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.